← Back
Data updated: Mar 29, 2026
INVAGEN PHARMS
CardiovascularNeurologyImmunology
Generics
INVAGEN PHARMS is a generic drug manufacturer focused on Cardiovascular, Neurology, Immunology. Key products include LEUPROLIDE ACETATE FOR DEPOT SUSPENSION.
2005
Since
55
Drugs
-
Trials
829
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
GABAPENTIN 2026-02-24
Labeling
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 32%
6 drugs
Neurology 26%
5 drugs
Immunology 16%
3 drugs
Oncology 16%
3 drugs
Metabolic 11%
2 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Merck big-pharma
Oncology, Cardiovascular, Immunology, Metabolic
Johnson & Johnson big-pharma
Oncology, Immunology, Cardiovascular, Metabolic
Eli Lilly big-pharma
Metabolic, Oncology, Immunology, Neurology
AstraZeneca big-pharma
Oncology, Cardiovascular, Metabolic, Immunology
Takeda big-pharma
Immunology, Oncology, Neurology, Metabolic
Active (29)
RIVAROXABAN LANREOTIDE ACETATE LINAGLIPTIN VILAZODONE HYDROCHLORIDE PENICILLAMINE TICAGRELOR LEUPROLIDE ACETATE FOR DEPOT SUSPENSION LANTHANUM CARBONATE VIGABATRIN OSELTAMIVIR PHOSPHATE RALOXIFENE HYDROCHLORIDE ZOLMITRIPTAN RIZATRIPTAN BENZOATE ATORVASTATIN CALCIUM LAMIVUDINE ALFUZOSIN HYDROCHLORIDE TROSPIUM CHLORIDE LEVETIRACETAM CALCIUM ACETATE TRANDOLAPRIL SERTRALINE HYDROCHLORIDE SIMVASTATIN TOPIRAMATE LISINOPRIL LISINOPRIL AND HYDROCHLOROTHIAZIDE NABUMETONE NADOLOL AMANTADINE HYDROCHLORIDE BENZTROPINE MESYLATE
Discontinued (24)
BUPROPION HYDROCHLORIDE GABAPENTIN PREGABALIN AMLODIPINE BESYLATE MECLIZINE HYDROCHLORIDE SEVELAMER CARBONATE QUINAPRIL HYDROCHLORIDE ESCITALOPRAM OXALATE NAPROXEN TERBINAFINE HYDROCHLORIDE PHENTERMINE HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE WARFARIN SODIUM FENOFIBRATE (MICRONIZED) ZONISAMIDE COLESEVELAM HYDROCHLORIDE ZOLPIDEM TARTRATE CYCLOBENZAPRINE HYDROCHLORIDE CITALOPRAM HYDROBROMIDE GEMFIBROZIL QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE FOSINOPRIL SODIUM MEPROBAMATE
Company Info
- First Approval
- 2005-04-20
- Latest
- 2026-02-20
- Applications
- 68